Clonidine facilitates controlled hypotension in adolescent children

Area of Science:

• Anesthesiology
• Pediatric Surgery
• Pharmacology

Background:

• Controlled hypotension is crucial in oromaxillofacial surgery.
• Optimizing anesthetic and adjunct medication is essential for pediatric patients.
• Clonidine's potential role in pediatric anesthesia requires further investigation.

Purpose of the Study:

• To evaluate clonidine's efficacy in reducing anesthetic requirements for controlled hypotension in pediatric oromaxillofacial surgery.
• To assess the impact of clonidine on preoperative sedation, hemodynamic responses, and recovery.
• To determine if clonidine can minimize the need for additional hypotensive agents like labetalol.

Main Methods:

• A randomized, double-blinded, placebo-controlled trial involving 39 healthy children aged 10-16 years.
• Administration of clonidine (5 µg/kg) or placebo preoperatively.
• Monitoring of anesthetic (isoflurane, fentanyl) and adjunct (labetalol) requirements, hemodynamic parameters, and recovery characteristics.

Main Results:

• Clonidine significantly reduced the required doses of isoflurane and fentanyl.
• Fewer patients in the clonidine group needed labetalol for blood pressure control.
• Clonidine demonstrated a trend towards faster recovery and shorter recovery room stays.
• Observer-rated sedation was higher in the clonidine group, with no difference in self-assessed anxiety.

Conclusions:

• Clonidine is an effective adjunct for achieving controlled hypotension in pediatric oromaxillofacial surgery.
• It allows for reduced doses of anesthetics and analgesics, improving hemodynamic stability.
• Clonidine facilitates a smoother and potentially faster recovery process in pediatric surgical patients.